PF3D7_0813300

PfNPM (PF3D7_0813300) is a nucleoplasmin-like histone-binding protein of Plasmodium falciparum that acts as a non-canonical histone chaperone in early blood-stage parasites (PMID:40049416). Its N-terminal core domain adopts the characteristic pentameric doughnut fold and assembles into a stable pentamer in solution (PMID:40049416). Through its acidic tracts, PfNPM binds assembled H2A/H2B and H3/H4 histone dimers with equimolar stoichiometry, with H3/H4 showing higher affinity — attributed to stronger electrostatic interactions — and apparently competing with H2A/H2B for a shared site on the distal face (PMID:40049416). Despite this histone-binding activity, PfNPM does not interact with nucleosome core particles and shows no nucleosome assembly activity in vitro, indicating that it is not directly engaged in histone deposition onto genomic DNA (PMID:40049416). Consistent with a chromatin-associated role restricted to a defined developmental window, PfNPM localizes predominantly to the nucleus and is expressed only in the ring and trophozoite stages (PMID:40049416). Beyond these findings, no further mechanistic detail — including its in vivo function, regulatory partners, or the basis of its non-canonical behavior — has been characterized in the available corpus.

1. 2025 High

   Establishing the quaternary architecture of PfNPM was needed to place it within the nucleoplasmin/histone-chaperone family; the crystal structure resolved this by showing its core domain forms the signature pentamer.

   Evidence X-ray crystallography of the N-terminal core domain with solution biochemistry confirming the pentameric state

   PMID:40049416

   Open questions at the time

   • Structure limited to the N-terminal core domain; the acidic tracts and full-length assembly are not structurally resolved
   • No structure of PfNPM bound to histones
2. 2025 High

   Whether PfNPM engages histones and by what determinants was unknown; binding assays plus acidic-tract mutagenesis showed it binds H2A/H2B and H3/H4 dimers via its acidic tracts, defining it as a histone-binding protein.

   Evidence Affinity binding assays with equimolar stoichiometry determination and acidic-tract mutagenesis

   PMID:40049416

   Open questions at the time

   • The structural basis of dimer recognition is not mapped
   • In vivo relevance of these interactions untested
3. 2025 Medium

   To understand how PfNPM discriminates between histone types, competition assays indicated H2A/H2B and H3/H4 likely share the distal-face site, with the higher-affinity H3/H4 able to displace H2A/H2B.

   Evidence Competition binding/interaction assays inferring a shared site from relative affinities

   PMID:40049416

   Open questions at the time

   • The shared binding site is inferred from affinity data, not confirmed by structural mapping
   • Single-lab study without independent replication
4. 2025 Medium

   Whether PfNPM performs canonical nucleosome assembly was tested directly; it neither binds nucleosome core particles nor assembles nucleosomes in vitro, distinguishing it from classical histone-deposition chaperones.

   Evidence In vitro nucleosome binding and nucleosome assembly assays (negative result)

   PMID:40049416

   Open questions at the time

   • Negative in vitro result from a single lab; assay conditions may not capture all functions
   • The actual cellular role of PfNPM histone binding remains undefined
5. 2025 Medium

   To connect biochemistry to biology, localization and expression profiling placed PfNPM in the nucleus specifically during ring and trophozoite stages, bounding its function to early blood-stage chromatin biology.

   Evidence Immunofluorescence assay for subcellular localization and stage-specific expression

   PMID:40049416

   Open questions at the time

   • Single localization method without functional consequence linked to localization
   • No genetic loss-of-function to establish stage-specific requirement

• The physiological function of PfNPM's non-canonical histone binding — including its in vivo essentiality, regulatory partners, and how histone chaperoning without nucleosome assembly contributes to early blood-stage parasite biology — remains unresolved.
• No gene knockout/knockdown phenotype reported
• No identified in vivo interacting partners or complex
• Cellular role of histone binding absent nucleosome assembly undefined